Literature DB >> 35288698

A probiotic supplement boosts response to cancer immunotherapy.

Lisa Derosa1,2,3,4, Laurence Zitvogel5,6,7,8,9.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35288698     DOI: 10.1038/s41591-022-01723-4

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.

Authors:  Yusuke Tomita; Tokunori Ikeda; Shinya Sakata; Koichi Saruwatari; Ryo Sato; Shinji Iyama; Takayuki Jodai; Kimitaka Akaike; Shiho Ishizuka; Sho Saeki; Takuro Sakagami
Journal:  Cancer Immunol Res       Date:  2020-07-14       Impact factor: 11.151

2.  Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo.

Authors:  K Isa; K Oka; N Beauchamp; M Sato; K Wada; K Ohtani; S Nakanishi; E McCartney; M Tanaka; T Shimizu; S Kamiya; C Kruger; M Takahashi
Journal:  Hum Exp Toxicol       Date:  2015-10-05       Impact factor: 2.903

3.  Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors.

Authors:  Nicholas J Salgia; Paulo G Bergerot; Manuel Caitano Maia; Nazli Dizman; JoAnn Hsu; John D Gillece; Megan Folkerts; Lauren Reining; Jeffrey Trent; Sarah K Highlander; Sumanta K Pal
Journal:  Eur Urol       Date:  2020-08-19       Impact factor: 20.096

Review 4.  Intestinal microflora of human infants and current trends for its nutritional modulation.

Authors:  Konstantinos C Mountzouris; Anne L McCartney; Glenn R Gibson
Journal:  Br J Nutr       Date:  2002-05       Impact factor: 3.718

5.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Authors:  Ayelet Sivan; Leticia Corrales; Nathaniel Hubert; Jason B Williams; Keston Aquino-Michaels; Zachary M Earley; Franco W Benyamin; Yuk Man Lei; Bana Jabri; Maria-Luisa Alegre; Eugene B Chang; Thomas F Gajewski
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

6.  Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.

Authors:  Hiromi Seki; Masaaki Shiohara; Tadao Matsumura; Natsuki Miyagawa; Mamoru Tanaka; Atsushi Komiyama; Susumu Kurata
Journal:  Pediatr Int       Date:  2003-02       Impact factor: 1.524

7.  Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.

Authors:  Lisa Derosa; Bertrand Routy; Marine Fidelle; Valerio Iebba; Laurie Alla; Edoardo Pasolli; Nicola Segata; Aude Desnoyer; Filippo Pietrantonio; Gladys Ferrere; Jean-Eudes Fahrner; Emmanuelle Le Chatellier; Nicolas Pons; Nathalie Galleron; Hugo Roume; Connie P M Duong; Laura Mondragón; Kristina Iribarren; Mélodie Bonvalet; Safae Terrisse; Conrad Rauber; Anne-Gaëlle Goubet; Romain Daillère; Fabien Lemaitre; Anna Reni; Beatrice Casu; Maryam Tidjani Alou; Carolina Alves Costa Silva; Didier Raoult; Karim Fizazi; Bernard Escudier; Guido Kroemer; Laurence Albiges; Laurence Zitvogel
Journal:  Eur Urol       Date:  2020-05-04       Impact factor: 20.096

8.  Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Authors:  Christine N Spencer; Jennifer L McQuade; Vancheswaran Gopalakrishnan; John A McCulloch; Marie Vetizou; Alexandria P Cogdill; Lorenzo Cohen; Giorgio Trinchieri; Carrie R Daniel; Jennifer A Wargo; Md A Wadud Khan; Xiaotao Zhang; Michael G White; Christine B Peterson; Matthew C Wong; Golnaz Morad; Theresa Rodgers; Jonathan H Badger; Beth A Helmink; Miles C Andrews; Richard R Rodrigues; Andrey Morgun; Young S Kim; Jason Roszik; Kristi L Hoffman; Jiali Zheng; Yifan Zhou; Yusra B Medik; Laura M Kahn; Sarah Johnson; Courtney W Hudgens; Khalida Wani; Pierre-Olivier Gaudreau; Angela L Harris; Mohamed A Jamal; Erez N Baruch; Eva Perez-Guijarro; Chi-Ping Day; Glenn Merlino; Barbara Pazdrak; Brooke S Lochmann; Robert A Szczepaniak-Sloane; Reetakshi Arora; Jaime Anderson; Chrystia M Zobniw; Eliza Posada; Elizabeth Sirmans; Julie Simon; Lauren E Haydu; Elizabeth M Burton; Linghua Wang; Minghao Dang; Karen Clise-Dwyer; Sarah Schneider; Thomas Chapman; Nana-Ama A S Anang; Sheila Duncan; Joseph Toker; Jared C Malke; Isabella C Glitza; Rodabe N Amaria; Hussein A Tawbi; Adi Diab; Michael K Wong; Sapna P Patel; Scott E Woodman; Michael A Davies; Merrick I Ross; Jeffrey E Gershenwald; Jeffrey E Lee; Patrick Hwu; Vanessa Jensen; Yardena Samuels; Ravid Straussman; Nadim J Ajami; Kelly C Nelson; Luigi Nezi; Joseph F Petrosino; P Andrew Futreal; Alexander J Lazar; Jianhua Hu; Robert R Jenq; Michael T Tetzlaff; Yan Yan; Wendy S Garrett; Curtis Huttenhower; Padmanee Sharma; Stephanie S Watowich; James P Allison
Journal:  Science       Date:  2021-12-23       Impact factor: 47.728

Review 9.  Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease.

Authors:  Magdalena K Stoeva; Jeewon Garcia-So; Nicholas Justice; Julia Myers; Surabhi Tyagi; Madeleine Nemchek; Paul J McMurdie; Orville Kolterman; John Eid
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.

Authors:  Nazli Dizman; Luis Meza; Paulo Bergerot; Marice Alcantara; Tanya Dorff; Yung Lyou; Paul Frankel; Yujie Cui; Valerie Mira; Marian Llamas; Joann Hsu; Zeynep Zengin; Nicholas Salgia; Sabrina Salgia; Jasnoor Malhotra; Neal Chawla; Alex Chehrazi-Raffle; Ramya Muddasani; John Gillece; Lauren Reining; Jeff Trent; Motomichi Takahashi; Kentaro Oka; Seiya Higashi; Marcin Kortylewski; Sarah K Highlander; Sumanta K Pal
Journal:  Nat Med       Date:  2022-02-28       Impact factor: 87.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.